Literature DB >> 26588456

Short-term mortality following surgical procedures for the diagnosis of pediatric brain tumors: outcome analysis in 5533 children from SEER, 2004-2011.

Todd C Hankinson1,2, Roy W R Dudley3, Michelle R Torok2, Mohana Rao Patibandla1, Kathleen Dorris4, Seerat Poonia5, C Corbett Wilkinson1, Jennifer L Bruny6, Michael H Handler1, Arthur K Liu7.   

Abstract

OBJECT Thirty-day mortality is increasingly a reference metric regarding surgical outcomes. Recent data estimate a 30-day mortality rate of 1.4-2.7% after craniotomy for tumors in children. No detailed analysis of short-term mortality following a diagnostic neurosurgical procedure (e.g., resection or tissue biopsy) for tumor in the US pediatric population has been conducted. METHODS The Surveillance, Epidemiology and End Results (SEER) data sets identified patients ≤ 21 years who underwent a diagnostic neurosurgical procedure for primary intracranial tumor from 2004 to 2011. One- and two-month mortality was estimated. Standard statistical methods estimated associations between independent variables and mortality. RESULTS A total of 5533 patients met criteria for inclusion. Death occurred within the calendar month of surgery in 64 patients (1.16%) and by the conclusion of the calendar month following surgery in 95 patients (1.72%). Within the first calendar month, patients < 1 year of age (n = 318) had a risk of death of 5.66%, while those from 1 to 21 years (n = 5215) had a risk of 0.88% (p < 0.0001). By the end of the calendar month following surgery, patients < 1 year (n = 318) had a risk of death of 7.23%, while those from 1 to 21 years (n = 5215) had a risk of 1.38% (p < 0.0001). Children < 1 year at diagnosis were more likely to harbor a high-grade lesion than older children (OR 1.9, 95% CI 1.5-2.4). CONCLUSIONS In the SEER data sets, the risk of death within 30 days of a diagnostic neurosurgical procedure for a primary pediatric brain tumor is between 1.16% and 1.72%, consistent with contemporary data from European populations. The risk of mortality in infants is considerably higher, between 5.66% and 7.23%, and they harbor more aggressive lesions.

Entities:  

Keywords:  30-day mortality; ACS NSQIP = American College of Surgeons National Quality Improvement Program; AT/RT = atypical teratoid/rhabdoid tumor; GTR = gross-total resection; ICD-O-3 = International Classification of Diseases for Oncology, 3rd Edition; NIS = Nationwide Inpatient Sample; NOS = not otherwise specified; NRTC = National Registry of Childhood Tumors; PNET = primitive neuroectodermal tumor; SEER = Surveillance, Epidemiology and End Results; STR = subtotal resection; Surveillance, Epidemiology and End Results; oncology; pediatric brain tumor

Mesh:

Year:  2015        PMID: 26588456     DOI: 10.3171/2015.7.PEDS15224

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  15 in total

1.  Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and End Results database.

Authors:  Jeremy T Moreau; Todd C Hankinson; Sylvain Baillet; Roy W R Dudley
Journal:  NPJ Digit Med       Date:  2020-01-30

2.  Clinicopathological features and microsurgical outcomes for giant pediatric intracranial tumor in 60 consecutive cases.

Authors:  Ailing Guo; Vigneyshwar Suresh; Xianzhi Liu; Fuyou Guo
Journal:  Childs Nerv Syst       Date:  2017-02-08       Impact factor: 1.475

3.  Pediatric versus adult meningioma: comparison of epidemiology, treatments, and outcomes using the Surveillance, Epidemiology, and End Results database.

Authors:  Roy W R Dudley; Michelle R Torok; Sarah Randall; Benjamin Béland; Michael H Handler; Jean M Mulcahy-Levy; Arthur K Liu; Todd C Hankinson
Journal:  J Neurooncol       Date:  2018-03-09       Impact factor: 4.130

4.  The effect of NACHRI children's hospital designation on outcome in pediatric malignant brain tumors.

Authors:  Daniel A Donoho; Timothy Wen; Jonathan Liu; Hosniya Zarabi; Eisha Christian; Steven Cen; Gabriel Zada; J Gordon McComb; Mark D Krieger; William J Mack; Frank J Attenello
Journal:  J Neurosurg Pediatr       Date:  2017-06-02       Impact factor: 2.375

5.  Epidemiology and prognostic factors of pediatric brain tumor survival in the US: Evidence from four decades of population data.

Authors:  Md Jobayer Hossain; Wendi Xiao; Maliha Tayeb; Saira Khan
Journal:  Cancer Epidemiol       Date:  2021-05-01       Impact factor: 2.890

6.  A novel risk classification system for 30-day mortality in children undergoing surgery.

Authors:  Oguz Akbilgic; Max R Langham; Arianne I Walter; Tamekia L Jones; Eunice Y Huang; Robert L Davis
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

7.  Clinicopathological characteristics and survival in colorectal signet ring cell carcinoma: a population-based study.

Authors:  Luo-Luo Yang; Min Wang; Ping He
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.379

8.  Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and End Results database.

Authors:  Jeremy T Moreau; Todd C Hankinson; Sylvain Baillet; Roy W R Dudley
Journal:  NPJ Digit Med       Date:  2020-01-30

9.  Comparison of pediatric and adult medullary thyroid carcinoma based on SEER program.

Authors:  Zhuang Zhao; Xiang-Dang Yin; Xu-He Zhang; Zhi-Wen Li; Dun-Wei Wang
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

10.  The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma.

Authors:  Zhuang Zhao; Na Yan; Shu Pan; Dun-Wei Wang; Zhi-Wen Li
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.